The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

Immunogenic cell death (ICD) is a regulated form of cell death that induces the activation of
both innate and adaptive immune responses through the release of damage-associated …

Pancreatic cancer (PC) is a highly malignant tumour of the digestive system with poor
therapeutic response and low survival rates. Immunotherapy has rapidly developed in …

Pancreatic ductal adenocarcinoma (PDAC) is caused by genetic mutations in four genes:
KRAS proto-oncogene and GTPase (KRAS), tumor protein P53 (TP53), cyclin-dependent …

Pancreatic cancer poses a significant challenge within the field of oncology due to its
aggressive behaviour, limited treatment choices, and unfavourable outlook. With a mere …

Introduction Immunogenic cell death (ICD) is a sort of regulated cell death (RCD) sufficient to
trigger an adaptive immunological response. According to the current findings, ICD has the …

Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), stands as the
fourth leading cause of cancer-related deaths in the United States, marked by challenging …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid malignancies,
characterized by its aggressiveness and metastatic potential, with a 5-year survival rate of …